Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

9.49
-0.0500-0.52%
Post-market: 9.48-0.0100-0.11%19:59 EDT
Volume:626.95K
Turnover:5.85M
Market Cap:39.75M
PE:- -
High:9.53
Open:9.32
Low:9.17
Close:9.54
52wk High:33.81
52wk Low:8.87
Shares:4.19M
Float Shares:4.19M
Volume Ratio:1.03
T/O Rate:14.97%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids

Stock News
·
Sep 07

Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity

Reuters
·
Sep 07

Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation

TIPRANKS
·
Sep 07

Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial

TIPRANKS
·
Sep 05

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 05

Sector Update: Healthcare

MT Newswires Live
·
Sep 04

Novo Nordisk Foundation to Set Up Quantum Chip Facility

MT Newswires Live
·
Sep 04

Surge in Crypto ETFs as Hawkish Fed Concerns Ease

Stock News
·
Sep 04

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 03

European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

MT Newswires Live
·
Sep 02

Novo Nordisk A/S Stock (NVO) Moved Up by 3.17% on Sep 2: What Signal Does It Send?

TradingKey
·
Sep 02

Pharma Giant Novo Nordisk’s Stock (NVO) Jumps Even as Deutsche Bank Repeats Sell Call

TIPRANKS
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Novo Nordisk Launches Wegovy Weight-Loss Pill in Germany

Reuters
·
Sep 01

New National Essential Medicines List Takes Effect September 1, Introducing Semaglutide Injection (Novotai) as a New Option for Primary Diabetes Management

Stock News
·
Sep 01

1 Weight Loss Drugs Effective Even at Low Starter Doses

Reuters
·
Sep 01

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Sep 01

Novo Nordisk Advances DKK 15 Billion Share Buyback Programme Through Late August 2026

TIPRANKS
·
Aug 31

Eli Lilly Expands Beyond Weight-Loss Dominance With Potential $2.88B Autoimmune Deal

Stock News
·
Aug 31

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29